Terminal differentiation programs in the nervous system are encoded by cis-regulatory elements that control the expression of terminal features of individual neuron types. We decoded the regulatory information that controls the expression of five enzymes and transporters that define the terminal identity of all eight dopaminergic neurons in the nervous system of the Caenorhabditis elegans hermaphrodite. We show that the tightly coordinated, robust expression of these dopaminergic enzymes and transporters (''dopamine pathway'') is ensured through a combinatorial cis-regulatory signature that is shared by all dopamine pathway genes. This signature is composed of an Ets domain-binding site, recognized by the previously described AST-1 Ets domain factor, and two distinct types of homeodomain-binding sites that act in a partially redundant manner. Through genetic screens, we identified the sole C. elegans Distalless/Dlx ortholog, ceh-43, as a factor that acts through one of the homeodomain sites to control both induction and maintenance of terminal dopaminergic fate. The second type of homeodomain site is a Pbx-type site, which is recognized in a partially redundant and neuron subtype-specific manner by two Pbx factors, ceh-20 and ceh-40, revealing novel roles of Pbx factors in the context of terminal neuron differentiation. Taken together, we revealed a specific regulatory signature and cognate, terminal selector-type transcription factors that define the entire dopaminergic nervous system of an animal. Dopaminergic neurons in the mouse olfactory bulb express a similar combinatorial transcription factor collective of Ets/Dlx/Pbx factors, suggesting deep phylogenetic conservation of dopaminergic regulatory programs.
[Keywords: cis-regulatory motif; differentiation; dopamine; elegans; homeodomain; neuron] Supplemental material is available for this article. Received May 6, 2013; revised version accepted May 16, 2013. The underlying basis of the functional and anatomical diversity of cell types in the nervous system is the differential expression of neuron-type-specific gene batteries, which are composed of terminal differentiation genes whose products define the specific properties of a mature neuron throughout its lifetime (Hobert et al. 2010) . These ''terminal differentiation'' or ''effector'' genes include, for example, neurotransmitter-synthesizing enzymes, neurotransmitter receptors, transporters, the many ion channels that tune the electric properties of a neuron, specific synaptic adhesion molecules, and many others. With this notion in mind, one approach to understand the generation of neuronal diversity is a ''bottom-up'' approach that focuses on studying the cis-regulatory principles by which the expression of terminal gene batteries is controlled. In spite of the conceptual promise of such an approach, the cis-regulatory architecture of neuronal gene batteries is generally poorly described.
The neurotransmitter dopamine controls a number of diverse behaviors across the animal kingdom (Iversen and Iversen 2007) . Dopaminergic neurons are molecularly defined through the coordinated expression of five genes (''dopamine pathway genes'') that encode proteins involved in the synthesis of dopamine (tyrosine hydroxylase [TH] , GTP-cyclohydrolase [GTPCH] , and aromatic amino acid decarboxylase [AAAD] ), packaging of dopamine into synaptic vesicles (vesicular monoaminergic transporter [VMAT] ), and reuptake of dopamine after synaptic release (dopamine transporter [DAT] ) (Fig. 1A; Flames and Hobert 2011) . Surprisingly little is known about the cis-regulatory elements and trans-acting factors that ensure coordinated expression of these specific genes. Understanding in detail how expression of these genes is regulated will provide insights into general regulatory principles of nervous system development, and such insights may also instruct our ability to generate this neuron type through reprogramming approaches in vitro or in vivo.
Dopaminergic neurons as well as dopamine pathway genes are phylogenetically conserved. The nematode Caenorhabditis elegans contains eight dopaminergic neurons in the hermaphroditic nervous system that fall into four distinct classes: the embryonically generated ADE, CEPD, and CEPV classes in the head and the postembryonically generated PDE class in the midbody ( Fig. 1A ; Sulston et al. 1975; Flames and Hobert 2011) . Using the amenability of C. elegans to transgenic reporter gene studies, we previously dissected the cis-regulatory control regions of the five dopamine pathway genes (cat-2/TH, cat-4/GTPCH, bas-1/AAAD, cat-1/VMAT, and dat-1/DAT) and identified a shared cis-regulatory motif-termed the dopaminergic (DA) motif-that is present in all five dopamine pathway genes (Flames and Hobert 2009) . Through mutational analysis, we found that the DA motif is required for all five genes to be expressed in all eight dopaminergic neurons (Fig. 1B) . We showed that this cis-regulatory motif is recognized by the Ets domain factor AST-1, a terminal selector-type transcription factor (Flames and Hobert 2009 ). Terminal selectors are transcription factors that define the terminal identity state of individual neuron types through direct regulation of many identity features of a specific neuron type (Hobert 2008 (Hobert , 2011 . Genetic removal of ast-1 results in a failure of all dopaminergic neurons to properly differentiate. A dopaminergic differentiation defect was Figure 1 . ETS-, Pbx-, and homeodomain-binding sites are required for dat-1 expression. (A) Schematic of the dopamine synthesis pathway genes and a transgenic worm expressing dat-1Tgfp, providing an overview of all dopaminergic neurons in C. elegans. (B) Summary of previous cis-regulatory analysis of dopamine pathway genes, illustrating with red bars the functionally required ETS domain-binding sites (EBSs) and sequence logo generated with all functional EBSs (Flames and Hobert 2009 ). (C) Analysis of the sufficiency of the EBS (labeled in red) from different dopamine pathway genes, flanked by >10 bp on either side, to drive expression in all dopaminergic neurons. Two (23) or three (33) copies of each sequence were cloned into the GFP reporter vector. For each construct, at least two independent lines were analyzed (n > 30 for each line). (+) More than 30% of the cells express GFP; (À) no GFP expression. (D) Mutational analysis of the predicted HD (labeled in blue) and Pbx (labeled in green) sites in the context of the trimerized dat-1 DA motif. For each construct, two independent lines were analyzed. (+) More than 30% of the cells express GFP; (À) no GFP expression; (+*) faint expression. also observed in olfactory bulb dopaminergic neurons of mice lacking the AST-1 homolog Etv1 (Flames and Hobert 2009) . One key issue that remained unresolved by our previous studies is the question of specificity. While the Ets domain transcription factor AST-1 and mouse Etv1 are required to generate dopaminergic neurons, they are not sufficient to do so, since both genes are expressed in multiple other, nondopaminergic neuron types. Similar specificity issues apply to many other terminal selectortype transcription factors that are required to define the identity of specific neuron types in vertebrate and invertebrate nervous systems but are often expressed in many other cell types as well (Hobert 2011; Holmberg and Perlmann 2012) .
Here we investigated this issue of specificity using a combination of cis-regulatory mutational analysis and genetic screening approaches. We found that ast-1 indeed does not act in isolation but rather through a combinatorial cis-regulatory signature that is present in the cisregulatory regions of all dopamine pathways genes. We identified three distinct types of trans-acting factors that recognize this cis-regulatory signature and show that these factors act together as a ''transcription factor collective'' (Junion et al. 2012 ) to ensure robust execution of the terminal differentiation program of dopaminergic neurons. Mouse homologs of this transcription factor collective are also expressed in a specific population of dopaminergic neurons in vertebrates, suggesting that our findings may also apply to mammals.
Results

A combinational cis-regulatory signature required for gene expression in dopaminergic neurons
We previously showed that a construct containing in triplicate a 31-base-pair (bp) element from the dat-1 promoter is sufficient to drive expression of a reporter gene in all eight dopaminergic neurons of the C. elegans hermaphrodite (Fig. 1C; Flames and Hobert 2009 ). This element contains an Ets domain-binding site (EBS), which we showed through deletion analysis to be essential for expression of dat-1 in dopaminergic neurons. We found functional EBSs in all of the dopamine pathway genes and therefore called the EBS the ''DA motif' ' (Fig. 1B; Flames and Hobert 2009) . Unexpectedly, when we tested the DA motifs from other dopamine pathway genes in a manner similar to our testing of the DA motif from dat-1 (i.e., EBS plus 13-14 bp of flanking sequences), we found that, unlike in the dat-1 case, DA motifs from none of the other four dopamine pathway genes were sufficient to drive expression in dopaminergic neurons (Fig. 1C ) even though each of the DA motifs is required to drive expression in all dopaminergic neurons (Flames and Hobert 2009) .
We therefore examined the 31-bp DA motif from the dat-1 promoter in more detail. Using MatInspector software analysis, we noted the presence of a predicted Pbxtype homeodomain (HD)-binding site [''GAT(N) 1-2 GAT''] and a canonical HD-binding site (''TAAT'') flanking the EBS. Mutating either site alone had partial effects on the expression of the reporter gene in dopaminergic neurons, while mutating both sites simultaneously-leaving, at the same time, the EBS intact-completely abolished expression of dat-1 in all dopaminergic neuron types (Fig. 1D) .
The DA motif-containing 30-to 32-bp elements from each of the other four dopamine pathway genes do not contain a combination of predicted Pbx-and canonical HD-binding sites, thereby providing a potential explanation for their insufficiency to drive expression in dopaminergic neurons. However, each of the minimal regions from all other dopamine pathway genes driving dopaminergic neuron expression contained a set of predicted Pbx-and HD-binding sites similar to those observed in the dat-1 promoter. We systematically mutated these predicted Pbx and HD sites in four of the five dopamine pathway genes and found that they are required for dopaminergic neuron expression ( Fig. 2A-D) . Unlike the EBS, which is essential for expression of all dopamine pathway genes (Flames and Hobert 2009) , the Pbx and HD sites act in a partially redundant manner, as detailed below.
dat-1/DAT The minimal dat-1 cis-regulatory element that drives expression in all dopaminergic neurons (400 bp) contains two predicted HD sites, one predicted Pbx site, and three functional EBSs (previously shown to be essential for expression) ( Fig. 2A) . Mutating a single HD site has no noticeable effect on dat-1 reporter gene expression in transgenic animals (data not shown), and mutating both HD sites has partial effects, similar to the effect of the HD mutation in the dat-1 DA motif construct (Figs. 1D, 2A; Supplemental Fig. 1 ). Mutating the one Pbx site has no effect (data not shown). However, mutating both HD sites and the one Pbx site together completely eliminates reporter gene expression in all dopaminergic neurons (even though the Ets sites are still present) ( Fig.  2A ; Supplemental Fig. 1 ), again in concordance with the effect seen in the dat-1 DA motif construct analysis.
cat-2/TH The minimal cat-2 cis-regulatory element that drives expression in all dopaminergic neurons (153 bp) also contains two potential canonical HD sites, one potential Pbx site, and one functional EBS (previously shown to be essential) (Fig. 2B) . The effects of the mutation of individual sites are similar to the dat-1 case. Mutation of the first HD site results in partial effects, whereas mutation of the second HD site does not have any effect. The combined mutation of both sites did not significantly increase the loss of expression (Fig. 2B) . Interestingly, the second HD site that shows no effect when mutated did not match the ATAAT consensus sequence found for the dat-1 HD sites (Supplemental Fig. 1) . Similarly, mutating the single Pbx site has a very mild effect. However, mutating the ATAAT HD site concomitantly with the Pbx site completely eliminates reporter gene expression in all dopaminergic neurons (even though the Ets site is still present) ( Fig. 2B; Supplemental Fig. 1 ).
cat-4/GTPCH In addition to the functionally required EBS, the minimal cat-4 cis-regulatory element that drives expression in all dopaminergic neurons (626 bp) has a substantial number of predicted HD-and Pbx-binding sites (Supplemental Fig. 1 ). Through analysis of a smaller cat-4 promoter region (136 bp) that is active only in a subset of dopaminergic neurons and subsequent mutation of all HD sites in this small region, we identified one HD site that matches the ATAAT consensus and whose mutation resulted in expression defects (Supplemental Fig. 1 ). Similar defects where seen when the mutation in this HD site was introduced in the context of the larger cat-4 element (which is active in all dopaminergic neurons) ( Fig. 2C; Supplemental Fig. 1 ). If combined with a mutation in a single Pbx site, expression of the reporter is completely eliminated ( Fig. 2C; Supplemental Fig. 1 ).
bas-1/AAAD The minimal bas-1 cis-regulatory element that drives expression in all dopaminergic neurons (143 bp) also contains one predicted HD site that matches the ATAAT consensus, two predicted Pbx sites, and two functional EBSs (previously shown to be essential) (Fig. 2D ). Mutating the single HD site has partial effects on bas-1 reporter gene expression in transgenic animals. Mutating either Pbx site alone has no or just partial effects, but if both Pbx sites are mutated, reporter gene expression is eliminated in all dopaminergic neurons (even though the EBS is still present) ( Fig. 2D; Supplemental Fig. 1 ).
In conclusion, members of the dopamine pathway are controlled by a common cis-regulatory signature composed of one or multiple essential EBSs and redundantly operating HD-and Pbx-binding sites (Fig. 2E) . Importantly, the combination of these three motifs is sufficient to drive specific expression in all dopaminergic neurons (Fig. 1D) . Notably, there is no defined ''motif grammar'' (Spitz and Furlong 2012) ; that is, no specific number, relative orientation, or spacing of the three motifs defines this cis-regulatory signature.
The sole C. elegans Distalless/Dlx ortholog, ceh-43, controls dopaminergic neuron differentiation
To identify the trans-acting factors that act through the ATAAT HD site, we turned to a collection of mutant animals that show abnormal expression of the dat-1Tgfp dopaminergic fate marker and that we isolated previously through automated sorting of EMS-mutagenized animals (Doitsidou et al. 2008) . One locus that we identified in this screen is the previously uncloned dopy-2 gene, represented by four mutant alleles: ot340, ot479, ot406, and ot345 (Doitsidou et al. 2008) . We mapped this mutant to a small interval on chromosome III by SNP linkage analysis and three-factor mapping (see Fig. 4A , below). Through a combination of transformation rescue analysis (Table 1; see Fig. 4A , below), whole-genome sequencing (Supplemental Table 1 ), RNAi phenocopy (Table 1) , and analysis of a genetic deletion in the locus (kindly provided by the C. elegans knockout facility at Tokyo Women's Medical School) (Fig. 3B,D) , we found that dopy-2 corresponds to the ceh-43 locus (Fig. 4A,B) . Mutations in the ceh-43 locus had not previously been described. From here on, we refer to dopy-2 as ceh-43.
ceh-43 encodes the sole C. elegans ortholog of the fly Distalless and vertebrate Dlx homeobox genes (Aspock and Burglin 2001) . In vertebrates, Dlx genes have been implicated in neuronal patterning (Panganiban and Rubenstein 2002) , but their roles in terminal neuron differentiation have not previously been described. The viability of the four alleles isolated from our screen (Table 1) and the nature of the mutations (Fig. 4B ) suggest that they are hypomorphic mutations. Thus, we further analyzed the involvement of ceh-43 in dopaminergic neuron differentiation using the tm480 deletion allele, a likely null allele. Since animals carrying this allele die as embryos, we analyzed mosaic animals that specifically lost ceh-43 expression in dopaminergic neurons (see the Material and Methods for details on mosaic analysis). These animals show defects in the expression of all dopamine pathway genes and in all dopaminergic neuron types in both the hermaphrodite (Fig. 3B,D ) and the male (data not shown).
The function of ceh-43 is not restricted to controlling the dopamine pathway genes-it also controls the expression of other terminal identity markers of dopaminergic neurons; namely, the trp-4 and asic-1 ion channel dat-1Tgfp 0% 6 0% 0% 6 0% 0% 6 0% 0% 6 0% 0% 0% 0% >100 cat-4Tgfp 0% 6 0% 0% 6 0% 0% 6 0% 0% 6 0% 0% 0% 0% >100 cat-2Tgfp 0% 6 0% 0% 6 %0 0% 6 0% 0% 6 0% 0% 0% 0% >100 bas-1Tgfp 0% 6 0% 0% 6 0% 0% 6 0% 0% 6 0% 0% 0% 0% >100 asic-1Tgfp 0% 6 0% 0% 6 0% 0% 6 0% 0% 6 0% 0% 0% 0% >100 ceh-43(ot345); dat-1Tgfp 0% 6 0% 18% 6 4% 6% 6 2% 0% 6 0% 41% 31% 58% 41 ceh-43(ot406); dat-1Tgfp 0% 6 0% 65.9% 6 5% 50% 6 5% 0% 6 0% 95% 16% 97% 60 ceh-43(ot479); dat-1Tgfp 100% 6 0% 100% 6 0% 0% 6 0% 0% 6 0% 100% nd 100% 60 ceh-43(ot340); dat-1Tgfp 100% 6 0% 100% 6 0% 0% 6 0% 0% 6 0% 100% nd 100% >100 ceh-43(ot340); cat-4Tgfp 100% 6 0% 100% 6 0% 0% 6 0% 0% 6 0% 100% nd 100% 40 ceh-43(ot340); asic-1Tgfp 100% 6 0% 100% 6 0% 0% 6 0% 0% 6 0% 100% nd 100% >100 ceh-43(ot340); cat-2Tgfp 100% 6 0% 100% 6 0% 0% 6 0% 0% 6 0% 100% nd 100% 40 ceh-43(ot340); bas-1Tgfp 8% 6 4% 6% 6 3% 0% 6 0% 0% 6 0% 8% 0% 14% 25 ceh-43(ot340); dat-1Tgfp 100% 6 0% 100% 6 0% 0% 6 0% 0% 6 0% 100% 0% 0% 40 ceh-43(ot340); dat-1Tgfp; 2.5% 6 5% 5% 6 6% 0% 6 0% 0% 6 0% 0% nd 0% 6 0% 40 Ex [ceh-43 fosmid ] ceh-43(ot340); dat-1Tgfp; 84.3% 6 9% 100% 6 0% 0% 6 0% 0% 6 0% 75% nd 75% 35 Ex [ceh-43 DEL_fosmid ] eri-1;lin-15b; dat-1Tgfp 0% 6 0% 0% 6 0% 0% 6 0% 12% 6 3.3% 18% nd 18% 50 empty vector RNAi eri-1;lin-15b; dat-1Tgfp 21% 6 4% 30% 6 4.5% 36% 6 4.7% 33% 6 4.6% 79% nd 79% 52 ceh-43 RNAi gfp(À) refers to dopaminergic neurons showing absence of gfp expression. Adult animals were scored. (nd) Not determined. a Reporters were as follows: vtIs1 (dat-1Tgfp); otIs225 (cat-4Tgfp); otIs254 (cat-2Tgfp); otIs226 (bas-1Tgfp); otIs236 (asic-1Tgfp). and no effect on expression of a panneuronal marker (C). For mosaic analysis, inviable null mutant ceh-43(tm480) animals were balanced with an extrachromosomal array that harbors a rescuing fosmid that contains the ceh-43 locus and a dat-1TmCherry expression construct that allows assessing for the presence or absence of the array in specific dopaminergic neurons. For phenotypic output, expression of a chromosomally integrated, gfp-based fate marker was examined. (E) Ectopic expression of ceh-43 under control of the heat shock leads to embryonic arrest and induction of dat-1Tgfp expression in additional cells. The heat shock was applied at the end of gastrulation (;300 min after fertilization), and animals were scored ;16 h after heat shock. genes (Table 1 ; data not shown). The expression of a panneuronal marker, rab-3, is not affected (Fig. 3C ), indicating that ceh-43 does not affect the generation of dopaminergic neurons but affects the adoption of a specific neuronal identity. This phenotype is similar to the loss of the trans-acting factor for the Ets-binding site, AST-1 (Flames and Hobert 2009) .
Two missense mutations in the ceh-43 locus, identified through our EMS screen, revealed weaker defects (Figs. 3A, 4B; Table 1 ). Notably, two other alleles (ot479 and ot340) are partially overlapping, <2-kb deletions that reside >7 kb upstream of the ceh-43 locus ( Fig. 4B ; Supplemental Table 1 ).
Both alleles fail to complement the missense alleles (Doitsidou et al. 2008) . In these deletion alleles, a highly penetrant loss of dopaminergic neuron fate is restricted entirely to the CEPD and CEPV neuron types, while ADE and PDE neuron types are unaffected ( Fig. 3A ; Table 1 ). As we show below, both deletions eliminate cis-regulatory elements required for expression of ceh-43 in the CEPD and CEPV neurons.
We further corroborated the notion that ceh-43 acts through the ATAAT motifs by using an in vitro approach in which we tested whether bacterially produced CEH-43 protein can bind to regulatory elements from four of the Mapping and rescue of the dopy-2 locus. ot340 was mapped with high-throughput SNP mapping between À7 and À1 cM on LGIII. This interval was further narrowed down to five genes using three-factor mapping (ot340 was located between unc-93 and dpy-17), deficiency mapping (deficiency strain BC4637 failed to complement, whereas NG2618 and BC4697 complemented ot340), and fosmid rescue (fosmids were injected in three pools of 10; red pool rescued, and subsequently, fosmids in the rescuing pool were injected as single fosmids; only fosmid WRM0633cC03 rescued). RNAi against ceh-43 recapitulated the phenotype. (B) Mutant alleles of the ceh-43 locus. Red lines indicate the deletion alleles. Blue boxes of the gene structure denote the homeodomain. The sequence alignment shows part of the homeodomain, which is affected in the ot406 allele. (C) EMSAs with CEH-43 protein on dat-1, cat-1, cat-4, and cat-2 regulatory elements. CEH-43 binds to ATAAT-containing elements in dat-1, cat-1, cat-4, and cat-2, in which mutation of ATAAT affects reporter expression in vivo (arrowhead). Mutation of the ATAAT motifs in dat-1 and cat-1 abolishes binding in vitro. CEH-43 does not bind to other TAAT-containing sequences in cat-2 (negative control; left) or cat-4 (negative control; right), in which mutation of TAAT has no effect on reporter activity in vivo. dopamine pathway genes. We readily detected such binding in gel shift assays (Fig. 4C ). This in vitro binding was abrogated when the same ATAAT motifs that disrupted activity in the in vivo reporter gene assay were mutated (Fig. 4C ). This binding is not the result of unspecific binding to the TAAT core motif, since other TAAT motifs in the minimal regulatory regions that do not match to the ATAAT consensus and showed no activity in the in vivo reporter assay do not bind CEH-43 (Fig. 4C, negative controls) . Two other ceh-43 targets that we identified in other cellular contexts also contain functional ATAAT-binding sites and bind CEH-43 in vitro (L Cochella, J Etchberger, N Abe, and O Hobert, unpubl. data) .
ceh-43 not only is required to express terminal fate markers of dopaminergic neurons, but is sufficient to do so, at least in some cellular contexts. When misexpressed under control of a ubiquitous and inducible heat-shock promoter, up to twice as many dopamine marker-positive cells can be generated (Fig. 3E) . The extent of ectopic dopaminergic neuron induction upon heat-shockedinduced ceh-43 expression is similar to the extent of ectopic dopaminergic neuron induction upon heat-shocked induction of ast-1 (Flames and Hobert 2009).
ceh-43 is expressed in dopaminergic neurons, and its function is continuously required to maintain the differentiated state of dopaminergic neurons
To examine ceh-43 expression, we generated a fosmidbased reporter in which we recombineered gfp at the C-terminal end of the ceh-43 locus in the context of an ;32-kb fosmid that contains several genes upstream of and downstream from ceh-43 (Fig. 5A) . Through colabeling with a dopaminergic neuron-specific marker, we found the fosmid reporter to be expressed in all dopaminergic neurons throughout the life of the neurons (Fig. 5B) . Expression can also be observed in some additional head and body neurons as well as nonneuronal cells (Supplemental Fig. 2a ). This expression was corroborated with immunostaining of endogenous CEH-43 protein using a pan-species anti-Distalless antibody (data not shown).
As assessed with immunostaining for CEH-43 and reporter transgene for ast-1 expression, despite the broad neuronal expression of both ceh-43 and ast-1, they uniquely overlap in dopaminergic neurons plus one additional pair of nondopaminergic neurons in the head and one additional neuron in the midbody region (Supplemental Fig. 2b) .
Introducing the smallest of the overlapping deletions present in the ot340 and ot479 alleles in the context of the fosmid reporter results in the loss of expression of the reporter specifically in the CEPD/V neuron types, demonstrating that these deletions affect relevant cis-regulatory elements (Fig. 5C) . Moreover, we found that ot340 mutants can be rescued with a wild-type fosmid containing the ceh-43 locus but not by a fosmid in which these regulatory elements are deleted (Fig. 5D) , corroborating the notion that ceh-43 acts autonomously at least in the CEP neurons to affect their terminal differentiation.
We noted that animals carrying a missense mutation in the homeobox of ceh-43 (ot406 allele) show a significantly more pronounced defect in the expression of dopamine markers in adults compared with young larvae (Fig. 5E ). This progressive loss of dopaminergic neuron identity indicates that ceh-43, like ast-1 (Flames and Hobert 2009) , is continuously required to maintain the differentiated state of dopaminergic neurons, a typical feature of terminal selector-type transcription factors (Hobert 2008) .
Cell type-and target gene-specific interactions of ceh-43 and ast-1
The coexpression of CEH-43 and AST-1 in mature dopaminergic neurons as well as the presence of cognate and functionally required CEH-43-and AST-1-binding sites in dopamine pathway genes suggest that both proteins cooperate to activate dopamine pathway genes. The level of cooperation may differ in distinct dopaminergic neuron types, as suggested by the observation that in ast-1-null mutant animals (gk463 allele), the dat-1 gene is still normally expressed in one dopaminergic neuron type: the CEPV neurons (Table 2 ). In ceh-43(ot406) hypomorphic animals, dat-1 expression in CEPV is also unaffected. In ast-1(gk463); ceh-43(ot406) double mutants, expression of dat-1 is now strongly affected in the CEPV neurons (Table 2 ). This finding suggests that, in the absence of ast-1, correct dat-1 expression in the CEPV neurons can still be ensured by ceh-43, but under such circumstances, even weak disruptions of ceh-43 activity will severely affect dat-1 expression. The genetic synergism between ceh-43 and ast-1 was further confirmed by the analysis of double-hypomorph mutants (Table 2 ). In ceh-43(ot406) mutants, dat-1 expression is only partially affected in the ADE and CEPD neurons, but this phenotype is greatly enhanced when the ceh-43(ot406) allele is combined with the ast-1(hd1) hypomorphic allele, which alone has no defects in dat-1 expression (Table 2) .
These results not only corroborate the genetic interaction of these two factors, but also make the point that individual dopamine pathway genes may display a differentially tuned requirement for individual trans-acting factors in specific cell types. In CEPVs, the loss of ast-1 can be tolerated in regard to dat-1 expression because ceh-43 can ensure robust dat-1 expression, but for other dopamine pathway genes, loss of ast-1 alone results in strong defects in expression. Moreover, this is not a general compensatory role for ceh-43 because in the other dopaminergic neurons, the presence of ceh-43 cannot compensate for a complete ast-1 loss in regard to dat-1 expression.
Two distinct Pbx genes constitute the third component of the dopamine regulatory signature
To identify the factors that operate through the third cis-regulatory motif required for dopaminergic neuron expression, the predicted Pbx HD site, we turned to a candidate gene approach. The C. elegans genome codes for three Pbx genes: ceh-20, ceh-40, and ceh-60 (Van Auken et al. Mukherjee and Burglin 2007) . Functions for these genes in the nervous system have not previously been reported.
We examined functions for each of the three Pbx genes in the context of dopaminergic neuron development using deletion or missense alleles available for each of the loci (Fig. 6A) . We found that ceh-20-null mutants (ok541) show defects in dat-1Tgfp expression exclusively in the midbody dopaminergic PDE neuron class (Fig. 6B) . Similar dat-1Tgfp expression defects in the PDE neurons are observed in multiple ceh-20 alleles (Table 3) . Apart from dat-1Tgfp, expression of all other members of the dopamine pathway is also defective in the PDE neurons of ceh-20 mutants (Fig. 6B) . The effect of ceh-20 on some of the members of the pathway (e.g., cat-2) is stronger than expected from the mutation of the Pbx cis-regulatory site. This may either be indicative of cross-regulation of the trans-acting factors controlling the dopamine pathway genes (e.g., ceh-20 regulating dopamine pathway genes and also regulating ceh-43) or hint toward the presence of atypical cis-regulatory sites for ceh-20/Pbx.
As in the case of ast-1 and ceh-43, the function of ceh-20 is not restricted to controlling the dopamine pathway genes. ceh-20 also controls the expression of other terminal identity markers of dopaminergic neurons; namely, the trp-4 and asic-1 ion channel genes [12% of animals show missing trp-4Tgfp, and 80% show missing asic-1Tgfp in ceh-20(mu290) mutants; n > 30]. Consistent with a role in initiating and maintaining the PDE differentiation program, a ceh-20 reporter gene construct is expressed in the PDE neurons throughout their life (Fig. 6C) .
In a fraction of ceh-20(mu290) mutant animals, no neurons appear to be generated from the post-deirid lineage, which generates the dopaminergic PDE and glutamatergic PVD sensory neurons (10% of the animals (gk159) shows a dopaminergic neuron differentiation defect that is not significantly enhanced in the triple mutant ceh-20(ok541); ceh-40(gk159) ceh-60(ok1485). Apart from animals that lack dat-1Tgfp expression, we also frequently observed animals in which additional cells express dat-1Tgfp. We have not further pursued this phenotype. (F) Genetic interaction between Pbx genes and ceh-43. Quantification of cells expressing dat-1Tgfp. The defect in dat-1Tgfp expression in a Pbx double-mutant combination of ceh-20(mu290);ceh-40(gk159) alleles is enhanced by the presence of a hypomorphic ceh-43 allele (ot406). The effect is more than expected from simple additivity. Table 2 . Genetic interactions between ceh-43/Dll and ast-1
Wild type 0% 6 0% 0% 6 0% 0% 6 0% >100 ast-1(gk463) 3% 6 4% 100% 6 0% 100% 6 0% 70 ceh-43(ot406) 4% 6 4% 46% 6 5% 35% 6 5% 78 ast-1(gk463); ceh-43(ot406) 100% 6 0% 100% 6 0% 100% 6 0% 50 ast-1(hd1) 0% 6 0% 0% 6 0% 0% 6 0% 100 ceh-43(ot406) 0% 6 0% 59% 6 4% 39% 6 3.9% 152 ast-1(hd1); ceh-43(ot406) 0% 6 0% 92.8% 6 2.3% 46% 6 4.4% 124
Animals were scored at 25°C at the L1 stage. Numbers refer to the percentage of respective neuron that failed to express dat-1Tgfp (vtIs1).
generate no neurons in the post-deirid, 14% generate only one neuron, 37% generate the normal number of two neurons, and 39% generate more than two neurons; n = 49), suggesting lineage defects. However, the PDE differentiation defects in ceh-20 mutants are not merely due to PDE lineage defects because dat-1 expression is also lost in animals with an unaffected PDE lineage, as assessed by correct expression of the pan-neuronal rab-3 marker in PDE (Supplemental Fig. 3) . In contrast to ast-1 and ceh-43 (Fig. 3E) , ceh-20 alone is not able to induce the production of additional dopaminergic neurons upon heat-shock promoter-mediated misexpression (as assessed by ectopic dat-1Tgfp expression) (data not shown). Animals that coexpress heat-shock promoter-driven ceh-43, ast-1, and ceh-20 constructs show no more ectopic dopaminergic neuron production than animals expressing ceh-43 or ast-1 alone (data not shown).
The effect of ceh-20 loss of function is restricted to the PDE neurons, since the expression of several dopamine pathway genes is completely unaffected in head dopaminergic neurons ( Fig. 6B ; data not shown). Since our cisregulatory analysis indicates that putative Pbx-binding sites are required for the expression of dopamine pathway genes in not just PDE neurons but also all dopaminergic head neurons, we tested whether removal of other Pbx genes affected dopaminergic head neurons. ceh-40-null mutants, ceh-60-null mutants, and ceh-40 ceh-60 doublenull mutants did not show defects in dat-1Tgfp expression in any dopaminergic neuron type ( Fig. 6D; Table 3 ). However, removal of ceh-40 in a ceh-20 mutant background, which alone has no effect on head dopaminergic neurons, results in defects in dat-1Tgfp expression in head dopaminergic neurons ( Fig. 6D; Table 3 ). In contrast, combining the ceh-60 mutation with the ceh-20 mutation only shows very mild (<10% penetrant) differentiation defects of head dopaminergic neurons. The defect of the ceh-20; ceh-40 double mutants are not further enhanced in ceh-20; ceh-40 ceh-60 triple-null mutants ( Fig. 6E; Table 3 ). However, the ceh-20; ceh-40 doublemutant defects are significantly enhanced by removal of ceh-43/Distalless (ceh-43; ceh-20; ceh-40 triple mutants) (Fig. 6F) , which corroborates the genetic interactions among distinct members of the dopaminergic regulatory ensemble. Taken together, ceh-20 functions nonredundantly in the PDE neurons to control their differentiation but acts redundantly with ceh-40 in head dopaminergic neurons. Consistent with this notion, we could not detect expression of ceh-40 in the midbody PDE neuron but detected expression of both ceh-20 and ceh-40 in the head dopaminergic neurons (Supplemental Fig. 4) .
We examined the overlap of ast-1, ceh-43, and Pbx gene expression to assess whether their coexpression uniquely defines dopaminergic neurons. We detected coexpression of ast-1, ceh-43, and ceh-20 in at least one nondopaminergic neuron (SDQL). The two most likely possibilities that could explain this lack of specificity are that either there are still other components of the dopaminergic transcription factor collective that remain to be identified and are not expressed in SDQL (those are unlikely to be DNA-binding factors, since the ETS, HD, and Pbx sites are sufficient to exclusive drive gene expression in dopaminergic neurons) or, alternatively, repressive mechanisms could operate in SDQL to inhibit the expression of dopaminergic neuron identity.
We also investigated whether ast-1, ceh-43, and ceh-20 cross-regulate each other's expression. Focusing on the PDE neuron class, we found that ast-1 expression is unaffected in ceh-43 and ceh-20 mutants (data not shown). However, ast-1 is required for ceh-43 expression (Supplemental Fig. 5 ) but is not required for ceh-20 expression (data not shown). These results indicate that these factors act to some extent independently of one another.
Taken together, our reverse genetic analysis identified a third component of the regulatory signature of dopaminergic neuron terminal differentiation programs. As Table 3 . Pbx genes affecting dopaminergic neuron differentiation Loss of dat-1Tgfp expression in all or a subset of head neurons (ADE and CEPs)
Loss of dat-1Tgfp expression of midbody neurons (PDE) n Wild type 0% 6 0% 3% 6 2% 55 ceh-20(ok541) 0% 6 0% 55% 6 7% a 56 ceh-20(ay42) 0% 6 0% 54% 6 8% 39 ceh-20(ay38) 0% 6 0% 40% 6 8% b 39 ceh-20(mu290) 0% 6 0% 50% 6 7% c 56 ceh-40(gk159) 0% 6 0% 0% 6 0% 50 ceh-60(ok1485) 0% 6 0% 0% 6 0% 50 ceh-40(gk159), ceh-60(ok1485) 0% 6 0% 0% 6 0% 52 ceh-20(ok541); ceh-40(gk159) 38% 6 5% predicted by the cis-regulatory analysis, this third component is a Pbx gene. In one dopaminergic neuron type, only one Pbx gene is required; in other dopaminergic neuron types, a combination of Pbx genes act redundantly.
AST-1, CEH-43, and CEH-20 cooperate to activate dopamine pathway genes in a heterologous, cell-based cis-activation assay To further explore the mechanistic basis of the interaction of AST-1, CEH-43, and a Pbx factor in controlling and maintaining dopaminergic neuron identity, we turned to a yeast transcription assay (Topalidou et al. 2011) . We inserted the regulatory regions of two of the dopamine pathway genes, bas-1 and cat-2, upstream of the yeast minimal cyc-1 promoter to drive the expression of b-galactosidase in the presence of different combinations of AST-1, CEH-43/Dll, and CEH-20/Pbx. We found that expression of neither factor alone is able to induce gene expression, but expression of all three factors together results in very strong induction of gene expression (Fig. 7) . In double combinations, only combinations with AST-1 yield induction of gene expression, albeit at lower levels than the triple combination (Fig. 7) . These findings support a model in which all three factors work in a cooperative manner to control gene expression.
The partial activity of AST-1 in combination with either CEH-43 or CEH-20 observed in the yeast assay matches with the general theme revealed by the cis-regulatory analysis: While Ets-binding sites are always essential for reporter gene expression, the loss of either HD or Pbx cis-regulatory sites can sometimes be tolerated, likely because AST-1 can still operate with the remaining cofactor.
Discussion
We described here a regulatory signature that specifies the terminal differentiation program of all dopaminergic neurons in C. elegans. We found that a combination of three cis-regulatory motifs is sufficient to dictate exclusive gene expression in all dopaminergic neurons of the C. elegans nervous system. This cis-regulatory signature is recognized by a combination of three types of transacting factors: an Ets domain factor, a Dlx-type HD, and Pbx-type HD proteins. These proteins work as terminal selectors to initiate and maintain the terminally differentiated state of C. elegans dopaminergic neurons. The mutant phenotypes of all three types of regulatory factors are similar to each other and are also similar to the phenotypic consequences of removal of terminal selector transcription factors that control terminal differentiation of other C. elegans neuronal cell types (Hobert 2008 (Hobert , 2011 : Neurons are generated and still express panneuronal features but fail to adopt neuron-type-specific properties (in this case, the terminal features that define dopaminergic identity).
Early patterning roles have been described for Pbx genes in several different contexts in both vertebrates and invertebrates (Laurent et al. 2008 ), but a function of Pbx genes in directly controlling post-mitotic, terminal differentiation programs has not yet, to our knowledge, been described in any system to date. Notably, the role of C. elegans Pbx genes in controlling dopaminergic neuron fate appears to be independent of the function of Hox genes, which are common interaction partners for Pbx genes in many cellular contexts (Moens and Selleri 2006; Laurent et al. 2008) . The anterior-most expression boundary of the most anterior HOX cluster gene, ceh-13, does not cover the region where the dopaminergic neuron classes ADE, CEPD, and CEPV are located (Wittmann et al. 1997) . As expected, ceh-13-null mutants do not affect dopaminergic neuron marker gene expression (our unpublished observations). Even though the role of Pbx as a Hox cofactor has been well documented, Hoxindependent functions of Pbx family members have been described in several species, including C. elegans (Yang et al. 2005) , vertebrates (Ferretti et al. 2011) , and flies (e.g., Casares and Mann 2001; Bessa et al. 2002) . Intriguingly, one study in Drosophila has shown that the ceh-43 ortholog Distalless genetically interacts with the fly Pbx homolog Exd (Dong et al. 2000) . The function of worm Pbx genes in controlling dopaminergic neuron differentiation is also independent of another common cofactor of Pbx gene, the Meis-type homeobox gene. There is a single canonical Meis homolog in the C. elegans, encoded by the unc-62 loucs (Van Auken et al. 2002) , but animals carrying a null mutant allele of unc-62 show no reduction in the production of dopaminergic neurons (our unpublished observations).
As revealed through the use of a heterologous yeast transcriptional assay system, the Ets/Dlx/Pbx regulatory ensemble acts in a cooperative manner to activate gene expression. Cooperativity is also suggested by genetic interaction tests that show synergy (rather than additivity) in loss-of-function scenarios. The cooperativity is reminiscent of the terminal differentiation program executed by the cholinergic AIY interneuron class in C. elegans. Here again, two factors (the HD transcription factors ttx-3 and ceh-10), each expressed in a number of distinct neuron types, uniquely overlap in their expression in the AIY interneurons, where they cooperatively activate scores of terminal differentiation genes that define AIY interneuron identity (Wenick and Hobert 2004) . The key conceptual and mechanistic difference between the cooperativity of ttx-3/ceh-10 and ast-1/ceh-43/Pbx lies in what generally is referred to as the ''grammar'' of cis-regulatory logic; that is, the overall organization of the individual cis-regulatory motifs. In the case of the AIY-expressed, ttx-3/ceh-10-dependent regulatory elements, the two binding sites for TTX-3 and CEH-10 are precisely spaced and oriented to allow for cooperative binding. Contrasting such fixed grammar, the cis-regulatory regions that control dopaminergic neuron expression are composed of cis-regulatory sites (ETS domain, HD, and Pbx-binding site) that display no fixed spacing, relative orientation, or overall number of individual sites, yet the activity of the cis-acting factors is nevertheless cooperative, as determined by mutant analysis and heterologous transcription assays in yeast. A recently published study described a similar regulatory architecture for cardiac gene expression in Drosophila and proposed the term ''transcription factor collective'' (Junion et al. 2012) . In that case, five cardiogenic transcriptional regulators cooperatively activate target genes in the absence of a defined motif grammar, and in some target cases, only a subset of the these factors are bound. Our studies broaden this concept to a different cell type and organism, suggesting universality of this regulatory mechanism.
We further extend the transcription factor collective model by our ability to examine its activity in four distinct neuronal subclasses: ADE, CEPD, CEPV, and PDE. Even though these four dopaminergic classes share many molecular and functional features, these neurons have distinct lineage histories and distinct axo/dendritic projections and are located in different parts of the nervous system. Even though our cis-regulatory analysis in combination with our genetic analysis clearly shows that all four neuron classes employ this combination of regulatory factors, the extent of the involvement of individual factors differs for each individual dopamine pathway gene in individual dopaminergic neuron subtypes. For example, dat-1 expression critically depends on ast-1 expression in all neurons except for the CEPV neurons, in which ast-1 function can be compensated for by ceh-43 gene activity. Head dopaminergic neuron types rely on multiple Pbx genes, as a mutant phenotype is only evident in doublemutant combinations, while midbody dopaminergic neurons critically depend on only one Pbx gene (ceh-20) . The underlying common theme of all of these interactions may be that the presence of multiple factors ensures robust expression of the target genes of these transcription factors and that each cell and target gene may use slightly different although related means to ensure this robustness.
The same Ets/Dlx/Pbx regulatory signature that we describe here may also function in dopaminergic neurons in vertebrates. We showed previously that Etv1, a mouse homolog of ast-1, is required for the appropriate differentiation of olfactory dopaminergic neurons (Flames and Hobert 2009 ). The defects of Etv1 mutants, however, are not as pronounced as ast-1 mutant defects are; for example, while TH expression is affected by Etv1, DAT expression is not (Cave et al. 2010) . One potential explanation for this partial effect can be seen in the regulatory logic described here: Other factors that cooperate with Etv1 may partially compensate for its loss. In fact, the failure to see a loss of Dat expression in Etv1 mouse mutants (Cave et al. 2010 ) may precisely mirror the absence of a phenotype of dat-1 expression in the CEPV neurons of ast-1-null mutants; that is, the ast-1 phenotype is only revealed if a cooperating factor (in this case, ceh-43) is disabled.
The factors that cooperate with vertebrate Etv1 to ensure dopaminergic neuron differentiation in the olfactory bulb could be the same as we defined here in C. elegans. A null mutation of Dlx2 results in early specification defects of olfactory bulb neurons and a loss of TH-positive neurons (Qiu et al. 1995) . Dlx2 expression is maintained in adult dopaminergic neurons, and later function of Dlx2 in terminal differentiation specifically of the dopamine olfactory bulb neurons is suggested through expression of a dominant-negative form of Dlx2, which resulted in dopaminergic neuron specification defects (Brill et al. 2008) . To assess whether the third component of the worm Ets/Dlx/Pbx regulatory signature is also expressed in mouse olfactory bulb dopaminergic neurons, we stained mouse olfactory bulbs with a Pbx1/2/3 antibody and observed Pbx immunoreactivity in TH-positive neurons (Supplemental Fig. 6 ). Intriguingly, Pbx1 is expressed in the midbrain dopaminergic neurons, and Pbx1 mutants show dopaminergic axon pathfinding defects (Sgado et al. 2012) . These observations suggest that the regulatory code between olfactory bulb dopaminergic neuron specification and worm dopaminergic neuron specification could, at least in part, be phylogenetically conserved.
Materials and methods
DNA constructs and cis-regulatory analysis
All gfp-based reporter constructs were generated using the pPD95.75 vector as backbone and by subcloning into the multiple cloning site. Mutagenesis reactions were performed using the QuickChangeII XL site-directed mutagenesis kit (Stratagene). Constructs were injected or crossed into otIs181 (dat-1Tcherry; ttx-3Tcherry) to allow easy identification of dopaminergic neurons. All reporter constructs were injected at 50 ng/mL using rol-6(su1006) as a coinjection marker (100 ng/mL). For each construct, two or three independent lines were scored (at least 30 animals per line). Sequences of the wild-type minimal constructs are in the Supplemental Material, and the nature of the mutations introduced is indicated in Supplemental Figure 1 .
Cloning of dopy-2/ceh-43 ot340 was mapped with high-throughput SNP mapping (Davis et al. 2005 ) between À7 and À1 cM on LGIII. Three-factor mapping mapped ot340 between unc-93 and dpy-17. Deficiency mapping placed the ot340 locus within deficiency BC4637 but outside deficiencies NG2618 and BC4697. Fosmid rescue of pools of fosmids were injected, followed by single-fosmid injections of the fosmids included in the rescuing pool. Single-fosmid injection of WRM0633cC03 rescued the ot340 phenotype. Only five genes were included in the rescuing fosmid. RNAi against each of these genes was performed using a bacterial feeding protocol (Kamath and Ahringer 2003) in an eri-1;lin-15b;vtIs1 mutant background (Kennedy et al. 2004 ). RNAi against ceh-43 recapitulated the phenotype. Sanger sequencing revealed point mutations in the ceh-43 locus for ot406 and ot345 alleles but no mutation in alleles ot340 and ot479. Whole-genome sequencing using an Illumina platform followed by data analysis using MAQGene (Bigelow et al. 2009 ) of ot340 and ot479 revealed two overlapping deletions >7 kb upstream of ceh-43 CDS (Supplemental Table 1 ). Deletions were confirmed by Sanger sequencing to span genomic regions on LGIII from 4457789 to 4459806 (2018 bp) for ot340 and from 4458889 to 4459754 (866 bp) for ot479.
Fosmid recombineering and ceh-43 expression analysis ceh-43-containing fosmid WRM0633cC03 was tagged as described before (Tursun et al. 2009) Tgfp;ttx-3Tdsred;rol-6]). The ot479 deletion was engineered in the recombineered fosmid as described before (Tursun et al. 2009) ) was used. To determine ceh-43 expression in ast-1 mutants, strain MDH38 {ast-1(gk463) bli-2(e768) unc-4(e120);Ex[ast-1 cosmid ;ttx-3Tgfp;dat-1TmCherry];otIs339; otIs355} was used.
The ability of the recombineered fosmid with and without the deletion to rescue ceh-43(ot340) mutants was assessed using strains OH10412 {ceh-43(ot340);vtIs1; otEx4439[ceh-43 fosmid T gfp;ttx-3Trfp;rol-6]} and OH10424 {ceh-43(ot340); vtIs1;[ExDEL_ ceh-43 fosmid Tgfp;ttx-3Trfp;rol-6]}, respectively.
Mosaic analysis
The strain CH1890 {ceh-43(tm480)/qC1 e1259q339[gIs26]} was injected with ceh-43 fosmid WRM0633cC03 (15 ng/mL) and dat-1TmCherry (40 ng/mL) to generate the strain ceh-43 (tm480);Ex[ceh-43 fosmid ;dat-1TmCherry]. This balanced strain was then crossed with animals bearing chromosomally integrated, gfp-based transgenes that monitor expression of dopamine pathway genes. Mosaic animals were identified by the loss of dat-1TmCherry in one or more dopaminergic neurons, and the fate of these neurons was assessed by scoring the expression of the integrated transgene. Note that the experimental design of this mosaic analysis does not allow distinguishing between loss of the array and inability of the array to rescue the mutant phenotype; that is, animals that fail to show dat-1TmCherry may carry the array containing dat-1Tmcherry and the ceh-43 fosmid, but ceh-43 fails to rescue the dat-1 expression defect, and this is why no dat-1TmCherry expression is observed in the cell. This very failure of ceh-43 to rescue the expression of the dat-1T mCherry phenotype implies that ceh-43 mutation has an effect on dat-1 expression to begin with. Thus, any dopaminergic phenotype in ceh-43-rescued mutant worms attests to a role of che-43 in dopaminergic fate whether this phenotype is caused by loss of the array per se or its inability to rescue with 100% penetrance.
Ectopic expression of ceh-43 ceh-43 under control of the heat-shock promoter was injected into vtIs1 to generate the strain Ex[hsp-16.2Tceh-43;hsp-16.2TNLS-mCherry;ttx-3Tds-red];vtIs1. The heat shock was applied at the end of gastrulation (;300 min after fertilization), and animals were scored ;16 h after heat shock.
Protein purification, EMSA, and yeast transcription assay
Full-length His-tagged CEH-43 was expressed in BL21 cells and purified using Co 2+ chromatography. EMSAs were performed as previously described . For all EMSAs, CEH-43 was tested at two concentrations: 60 nM and 180 nM. Probe sequences are listed in the Supplemental Material.
For the yeast assays, the reporter plasmids bas-1pTlacZ and cat-2pTlacZ were constructed by cloning the 279 bp and 354 bp upstream of the ATG of the bas-1 and cat-2 genes, respectively, into the HindIII/XmaI sites of plasmid pXCZ55 (a gift from Mark Ptashne). Yeast strains expressing bas-1pT lacZ and cat-2pTlacZ were constructed by digesting plasmids with these DNAs with ApaI and integrating them in the URA locus of the yeast strain YPH499 (Stratagene). Positive colonies were identified using single-colony PCR. Yeast transformation was performed using the Liac/SS carrier DNA/PEG method (Gietz and Woods 2002) . Induction was achieved as described previously (Topalidou et al. 2011) , and cells were harvested when OD 600 = 1.5. Liquid b-galactosidase assays were performed as described by Reynolds et al. (2001) .
